Abstract
ABSTRACTBladder cancer is the ninth most common malignancy in the world. Transitional cell carcinoma (TCC), also referred to as urothelial carcinoma (UC) is the most common form of bladder cancer, occurring in 90% of cases. In this study, we explore urine-derived, 3-dimensional, canine TCC organoids as a possible model to study bladder TCC ex vivo. After establishing the cell lines, we subjected the 3D cells to RNA in situ hybridization (RNA-ISH) and cell viability assays. Overall, 3D cell culture from urine samples of TCC diagnosed canines expressed RNA biomarkers in a similar manner to parent tumors via RNA-ISH and showed more sensitivity to cisplatin treatment when compared to 2D human TCC cells. With further experimentation, canine TCC organoids could become an ideal model to study TCC ex vivo.
Publisher
Cold Spring Harbor Laboratory
Reference43 articles.
1. The present and future burden of urinary bladder cancer in the world
2. Cancer statistics, 2020
3. Multimodal management of muscle invasive bladder cancer;Curr Probl Cancer,2014
4. Abraham J , Gulley JL , Allegra CJ. The Bethesda Handbook of Clinical Oncology. Lippincott Williams & Wilkins; 2012. 682 p.
5. Transurethral resection of bladder tumour (TURBT);Transl Androl Urol,2020